Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betamethasone.
Betamethasone acetate is long-acting corticosteroid has anti-inflammatory and immunosuppressive effects. It can be administered parenterally to treat a number of disease states, including autoimmune illnesses, and topically to treat inflammatory skin conditions including eczema. Betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). Betamethasone injectable suspension is used to treat inflammation and pain from a variety of conditions. These conditions include multiple sclerosis, arthritis, and others.
Market Dynamics
The betamethasone acetate is used in various disease conditions such as renal disease, thus the increasing prevalence of renal disease is expected to drive the market growth over the forecast period. For instance, in July 2022, according to data provided by Center of Disease Control and Prevention (CDC), in 2020, more than 15% of the U.S. adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Moreover, according to same source CKD is more common in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%).
The betamethasone acetate is used in various disease condition such as respiratory diseases, thus the increasing prevalence of respiratory disease is expected to drive the betamethasone acetate market growth over the forecast period. For instance, in August 2021, according to the World Health Organization (WHO), in 2020 approximately, 65 million people had moderate to severe Chronic Obstructive Pulmonary Diseases (COPD) that accounts for 5% of deaths (41.9 deaths per 100 000 individuals) globally.
Key features of the study:
- This report provides in-depth analysis of the global betamethasone acetate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global betamethasone acetate market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global betamethasone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global betamethasone acetate market
Detailed Segmentation:
- Global Betamethasone Acetate Market, By Formulation:
- Global Betamethasone Acetate Market, By Route of Administration:
- Intramuscular
- Intra-articular
- Intradermal
- Global Betamethasone Acetate Market By Application:
- Respiratory Disease
- Renal Disease
- Gastrointestinal Disease
- Ophthalmic Disease
- Dermatological Disease
- Others
- Global Betamethasone Acetate Market By Age Group:
- Global Betamethasone Acetate Market By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Betamethasone Acetate Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Merck & Co., Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- American Regent, Inc.
- McKesson Medical-Surgical Inc.
- GNHIndia .com
- Lexicon Medical Supply
- Medline Industries, Inc.
- Caspian Tamin Pharmaceutical Co.
- Sandoz Canada Inc
- NorthWestPharmacy.com Inc.
- MEDISCA PHARMACEUTIQUE INC
- Exela Pharma Sciences, LLC
- Sanofi Pasteur Inc.
- Sorrento Therapeutics Inc.
“*” marked represents similar segmentation in other categories in the respective section.
